1. Home
  2. LNN vs MRVI Comparison

LNN vs MRVI Comparison

Compare LNN & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$114.13

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$8.90

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNN
MRVI
Founded
1954
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
LNN
MRVI
Price
$114.13
$8.90
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$113.00
$4.13
AVG Volume (30 Days)
95.0K
3.8M
Earning Date
04-02-2026
05-07-2026
Dividend Yield
1.35%
N/A
EPS Growth
12.81
14.29
EPS
4.22
N/A
Revenue
$676,368,000.00
$185,743,000.00
Revenue This Year
N/A
$12.54
Revenue Next Year
$4.74
$7.87
P/E Ratio
$27.05
N/A
Revenue Growth
11.41
N/A
52 Week Low
$97.27
$2.29
52 Week High
$148.00
$9.06

Technical Indicators

Market Signals
Indicator
LNN
MRVI
Relative Strength Index (RSI) 49.66 79.01
Support Level $111.23 $5.37
Resistance Level $120.01 N/A
Average True Range (ATR) 2.95 0.51
MACD 0.08 0.33
Stochastic Oscillator 38.14 99.73

Price Performance

Historical Comparison
LNN
MRVI

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: